![Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] - EMBL-EBI](https://cedclinic.com/wp-content/uploads/2026/06/ced-pexels-4226264-1-150x150.jpg "Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] - EMBL-EBI 12")
Cannabis Health Research: New Findings for June 2026
✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchSafetyDosingCBDTHCPolicyPain Why This Matters Clinicians need to understand cannabis drug interactions and…
Don’t Sweat It: Cannabinoid CB1 Receptors Reduce Sweating in a Mouse Model
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchNeurologySafetyTHCCBDMental HealthAnxiety Why This Matters Clinicians treating patients with hyperhidrosis…
CBD Gummies Effectiveness: What Real-World Use and Research Actually Show
✦ New CED Clinical Relevance #57 Clinical Context Background information relevant to the evolving cannabis medicine landscape. CBDResearchSleepAnxietyDosingSafetyHemp Why This Matters Clinicians need to understand that CBD gummies show…
Medical Cannabis: Doctors Prescribe Little THC and CBD #shorts
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDTHCDosingSafetyPolicyPain Why This Matters Clinicians need to understand that CBD monotherapy has limited…
![Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] - EMBL-EBI](https://cedclinic.com/wp-content/uploads/2026/06/ced-pexels-4226264-1-440x310.jpg "Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] – EMBL-EBI")
Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] – EMBL-EBI
✦ New CED Clinical Relevance #62 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologySafetyMental HealthCBDTHCAnxiety Why This Matters This research characterizing MAGL (monoacylglycerol…
CBD for Skin Care: Evidence-Based Benefits & Research
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CBDResearchAgingSafetyHempAnxietyMental Health Why This Matters Clinicians need to understand CBD's mechanism in…
Exilby Whole Plant Botanical Cannabis Treatment, Receives Marketing Authorization in Germany
✦ New CED Clinical Relevance#67 Notable Clinical InterestEmerging findings or policy developments worth monitoring closely. ResearchPolicyIndustrySafetyDosingTHCCBD Why This MattersThis approval establishes a regulated, standardized cannabis product with…
Avextra 10/10 Cannabis Extract in Sesame Linseed Oil Shows Promise
A Phase II randomized controlled trial evaluated Avextra 10/10 cannabis extract clinical trial for treating neurodegenerative diseases using a rigorous double-blind design. The study assessed both therapeutic benefits and safety profiles of this…
Limited Evidence for Topical CBD Pain Relief According to Recent Study
Recent research challenges widespread claims about topical CBD for pain relief, finding insufficient evidence to support its effectiveness for musculoskeletal soreness. While topical CBD for pain has gained popularity among consumers, clinical trials…
Can Cannabis Help Slow Alzheimer’s Disease? A Recent Study Says It Might – AOL
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. NeurologyResearchAgingCBDTHCMental HealthSafety Why This Matters I need the complete article summary to provide an…